









Markets
/
Stocks
/
nasdaq-lfwd
/

Lifeward Ltd

LFWD

0.563USD

+0.003+0.55%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

8.81MMarket Cap

LossP/E TTM



Lifeward Ltd

0.563

+0.003+0.55%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a good stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

121 / 207

Overall Ranking

278 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

5.500

Target Price

+882.49%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 365.67% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 25.66M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 47.90.

Overvalued

The company’s latest PE is -0.18, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.29M shares, decreasing 37.11% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 91.91K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.66.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.20, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 5.72M, representing a year-over-year decrease of 14.66%, while its net profit experienced a year-over-year decrease of 52.46%.

Score

Industry at a Glance

Previous score

6.20

Change



Financials

6.93

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.05

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

4.64

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.32

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -0.18, which is 271.20% below the recent high of -0.66 and -7705.06% above the recent low of -13.88.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 121/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Lifeward Ltd is 5.50, with a high of 10.00 and a low of 1.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

5.500

Target Price

+877.08%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Lifeward Ltd

LFWD

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 5.08, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 0.65 and the support level at 0.50, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.08

Change

0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.010

Neutral

RSI(14)

39.634

Neutral

STOCH(KDJ)(9,3,3)

43.938

Neutral

ATR(14)

0.033

Low Volatility

CCI(14)

-14.942

Neutral

Williams %R

64.363

Sell

TRIX(12,20)

-0.751

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

0.559

Buy

MA10

0.562

Buy

MA20

0.583

Sell

MA50

0.659

Sell

MA100

0.891

Sell

MA200

1.286

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 11.15%, representing a quarter-over-quarter increase of 90.72%. The largest institutional shareholder is James Simons, holding a total of 91.91K shares, representing 0.59% of shares outstanding, with 22.65% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Lind Partners, LLC

94.52K

-88.98%

Renaissance Technologies LLC

Star Investors

79.71K

+19.60%

Swinford (Michael)

65.04K

Jasinski (Lawrence J)

61.42K

-0.49%

National Bank of Canada

39.24K

+27535.21%

UBS Financial Services, Inc.

9.37K

+47.30%

Turk (Joseph E Jr)

33.13K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.01, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.16. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.